MedTrace Logo

Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.

NCT02160795 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-12-16

No results posted yet for this study

Summary

Background:

\- Pregnant women are encouraged to take the vitamin folate. It helps prevent some birth defects. Children of mothers who take it also have less risk of some cancers. Between 1993 and 1995, some women in China took the vitamin daily before and during early pregnancy. Another group did not. This study will follow up on children born to both sets of women. (The children were born between 1994 and 1996.) Researchers will use these data to study the link between folate and cancer in infants and children.

Objective:

\- To see if folate may reduce childhood cancer if women take it every day before and during early pregnancy.

Eligibility:

\- Mothers who took part in a Chinese folic acid study between 1993 and 1995 and their offspring.

Design:

* Mothers of children in the study will sign a consent form. The form lets the researchers review the child s medical history. They may also review data about their cancer diagnosis. The children will also sign a form.

Conditions

  • Pediatric Leukemia
  • Pediatric Brain Neoplasms
  • Other Pediatric Cancers

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Martha Linet, M.D. · National Cancer Institute (NCI)

Eligibility

Min Age
17 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-27
Primary Completion
2018-02-23
Completion
2018-10-09

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02160795 on ClinicalTrials.gov